LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872104. A total of 4 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $182,000 | -42.4% | 192,905 | -44.4% | 0.00% | – |
| Q4 2014 | $316,000 | +161.2% | 346,931 | +304.1% | 0.00% | – |
| Q3 2014 | $121,000 | -11.0% | 85,856 | +1.4% | 0.00% | – |
| Q2 2014 | $136,000 | +9.7% | 84,709 | +17.9% | 0.00% | – |
| Q1 2014 | $124,000 | -68.6% | 71,820 | -67.3% | 0.00% | – |
| Q4 2013 | $395,000 | -38.0% | 219,422 | -18.1% | 0.00% | – |
| Q3 2013 | $637,000 | +248.1% | 267,883 | +216.8% | 0.00% | – |
| Q2 2013 | $183,000 | -65.9% | 84,561 | -65.2% | 0.00% | – |
| Q4 2012 | $537,000 | -32.8% | 243,298 | -29.4% | 0.00% | – |
| Q3 2012 | $799,000 | +314.0% | 344,463 | +300.1% | 0.00% | – |
| Q2 2012 | $193,000 | +135.4% | 86,085 | +94.2% | 0.00% | – |
| Q1 2012 | $82,000 | – | 44,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 30,248,505 | $28,434,000 | 99.96% |
| Artal Group S.A. | 402,625,866 | $378,492,000 | 17.50% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 2,586,881 | $2,432,000 | 1.51% |
| NEA Management Company, LLC | 16,676,000 | $15,675,000 | 0.71% |
| Alden Global Capital LLC | 900,900 | $851,000 | 0.60% |
| Rhenman & Partners Asset Management AB | 1,594,805 | $1,506,000 | 0.25% |
| MASTERS CAPITAL MANAGEMENT LLC | 7,964,370 | $7,521,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 5,371,800 | $5,073,000 | 0.21% |
| Round Table Services, LLC | 151,280 | $143,000 | 0.11% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 250,000 | $236,000 | 0.09% |